1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co XNYS: LLY

Lilly(Eli) & Co Live Stock Price Today, Share Analysis and Chart

about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
774.16 11.21 (1.47%)
768.5K
XNYS Volume

XNYS 30 Jul, 2025 10:23 AM (EDT)

Regulatory Approval
Eli Lilly rises on Friday after EU regulator recommends approval of its Alzheimer's drug Kisunla See details
High Financial Strength
55.6 / 100
Expensive Valuation
26.3 / 100
Technically Neutral
49.7 / 100
Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..